Top compounds associated with response to RARS


Feature Type Standardized
Nominal ANOVA
mRNA FH535 GDSC1000 pan-cancer AAC 0.13 0.0003
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.11 0.0003
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.14 0.0004
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0004
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.12 0.0004
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.14 0.0004
Download CSV